|
1
|
Fayaz MS, Al-Qaderi AE and El-Sherify MS:
Metastatic renal cell carcinoma with undetectable renal mass
presenting as lymphadenopathy. CEN Case Rep. 6:36–38. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Zeng S, Jiang X, Lai D and Su Z:
SOX4 induces tumor invasion by targeting EMT-related pathway in
prostate cancer. Tumour Biol. 39:10104283176945392017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang JW, Gwak SY, Shim GA, Liu L, Lim YC,
Kim JM, Jung MG and Koo BS: EZH2 is associated with poor prognosis
in head-and-neck squamous cell carcinoma via regulating the
epithelial-to-mesenchymal transition and chemosensitivity. Oral
Oncol. 52:66–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xia P and Xu XY: Epithelial-mesenchymal
transition and gastric cancer stem cell. Tumour Biol.
39:10104283176983732017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M,
Guo YH, Shi J, Gong XD, Zhu YL, Liu F, et al: Overexpression of
FOXM1 is associated with EMT and is a predictor of poor prognosis
in non-small cell lung cancer. Oncol Rep. 31:2660–2668. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo W, Fang W, Li S and Yao K: Aberrant
expression of nuclear vimentin and related epithelial-mesenchymal
transition markers in nasopharyngeal carcinoma. Int J Cancer.
131:1863–1873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naber HP, Drabsch Y, Snaar-Jagalska BE,
ten Dijke P and van Laar T: Snail and Slug, key regulators of
TGF-β-induced EMT, are sufficient for the induction of single-cell
invasion. Biochem Biophys Res Commun. 435:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar MS, Armenteros-Monterroso E, East P,
Chakravorty P, Matthews N, Winslow MM and Downward J: HMGA2
functions as a competing endogenous RNA to promote lung cancer
progression. Nature. 505:212–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J and Wei JJ: HMGA2 and high-grade
serous ovarian carcinoma. J Mol Med (Berl). 91:1155–1165. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Y, Li W and Liao H: HMGA2 induces
epithelial-to-mesenchymal transition in human hepatocellular
carcinoma cells. Oncol Lett. 5:1353–1356. 2013.PubMed/NCBI
|
|
11
|
Liu B, Pang B, Hou X, Fan H, Liang N,
Zheng S, Feng B, Liu W, Guo H, Xu S, et al: Expression of
high-mobility group AT-hook protein 2 and its prognostic
significance in malignant gliomas. Hum Pathol. 45:1752–1758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Langelotz C, Schmid P, Jakob C, Heider U,
Wernecke KD, Possinger K and Sezer O: Expression of
high-mobility-group-protein HMGI-C mRNA in the peripheral blood is
an independent poor prognostic indicator for survival in metastatic
breast cancer. Br J Cancer. 88:1406–1410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Liu X, Li AY, Chen L, Lai L, Lin
HH, Hu S, Yao L, Peng J, Loera S, et al: Overexpression of HMGA2
promotes metastasis and impacts survival of colorectal cancers.
Clin Cancer Res. 17:2570–2580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xi YN, Xin XY and Ye HM: Effects of HMGA2
on malignant degree, invasion, metastasis, proliferation and
cellular morphology of ovarian cancer cells. Asian Pac J Trop Med.
7:289–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zou Q, Wu H, Fu F, Yi W, Pei L and Zhou M:
RKIP suppresses the proliferation and metastasis of breast cancer
cell lines through up-regulation of miR-185 targeting HMGA2. Arch
Biochem Biophys. 610:25–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao XP, Zhang H, Jiao JY, Tang DX, Wu YL
and Pan CB: Overexpression of HMGA2 promotes tongue cancer
metastasis through EMT pathway. J Transl Med. 14:262016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai J, Shen G, Liu S and Meng Q:
Downregulation of HMGA2 inhibits cellular proliferation and
invasion, improves cellular apoptosis in prostate cancer. Tumour
Biol. 37:699–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun J, Sun B, Zhu D, Zhao X, Zhang Y, Dong
X, Che N, Li J, Liu F, Zhao N, et al: HMGA2 regulates CD44
expression to promote gastric cancer cell motility and sphere
formation. Am J Cancer Res. 7:260–274. 2017.PubMed/NCBI
|
|
19
|
Dong J, Wang R, Ren G, Li X, Wang J, Sun
Y, Liang J, Nie Y, Wu K, Feng B, et al: HMGA2-FOXL2 axis regulates
metastases and epithelial-to-mesenchymal transition of
chemoresistant gastric cancer. Clin Cancer Res. 23:3461–3473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Jiang Z, Chen H, Wu X, Xiang J and
Peng J: MicroRNA-495 inhibits gastric cancer cell migration and
invasion possibly via targeting high mobility group AT-hook 2
(HMGA2). Med Sci Monit. 23:640–648. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Fu QZ, Pu L, Meng QG, Liu XF, Dong
SF, Yang JX and Lv GY: HMGA2 expression in renal carcinoma and its
clinical significance. J Med Biochem. 34:338–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Na N, Si T, Huang Z, Miao B, Hong L, Li H
and Qiu J and Qiu J: High expression of HMGA2 predicts poor
survival in patients with clear cell renal cell carcinoma. Onco
Targets Ther. 9:7199–7205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi Z, Wu D, Tang R, Li X, Chen R, Xue S,
Zhang C and Sun X: Silencing of HMGA2 promotes apoptosis and
inhibits migration and invasion of prostate cancer cells. J Biosci.
41:229–236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun M, Song CX, Huang H, Frankenberger CA,
Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C, et al:
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth
and metastasis. Proc Natl Acad Sci USA. 110:pp. 9920–9925. 2013;
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Natarajan S, Hombach-Klonisch S, Dröge P
and Klonisch T: HMGA2 inhibits apoptosis through interaction with
ATR-CHK1 signaling complex in human cancer cells. Neoplasia.
15:263–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang E, Cisowski J, Nguyen N, O'Callaghan
K, Xu J, Agarwal A, Kuliopulos A and Covic L: Dysregulated protease
activated receptor 1 (PAR1) promotes metastatic phenotype in breast
cancer through HMGA2. Oncogene. 35:1529–1540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaur H, Ali SZ, Huey L, Hütt-Cabezas M,
Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG, et
al: The transcriptional modulator HMGA2 promotes stemness and
tumorigenicity in glioblastoma. Cancer Lett. 377:55–64. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Micalizzi DS, Haber DA and Maheswaran S:
Cancer metastasis through the prism of epithelial-to-mesenchymal
transition in circulating tumor cells. Mol Oncol. 11:770–780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xia YY, Yin L, Jiang N, Guo WJ, Tian H,
Jiang XS, Wu J, Chen M, Wu JZ and He X: Downregulating HMGA2
attenuates epithelial-mesenchymal transition-induced invasion and
migration in nasopharyngeal cancer cells. Biochem Biophys Res
Commun. 463:357–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You
T: HMGA2 induces transcription factor Slug expression to promote
epithelial-to-mesenchymal transition and contributes to colon
cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ke Z, Caiping S, Qing Z and Xiaojing W:
Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal
transition in ovarian cancer by mediating PI3K/AKT pathway. Med
Oncol. 32:3682015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qiao B, He BX, Cai JH, Tao Q and King-Yin
Lam A: MicroRNA-27a-3p modulates the Wnt/β-catenin signaling
pathway to promote epithelial-mesenchymal transition in oral
squamous carcinoma stem cells by targeting SFRP1. Sci Rep.
7:446882017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu F, Zhang J, Hu G, Liu L and Liang W:
Hypoxia and TGF-β1 induced PLOD2 expression improve the migration
and invasion of cervical cancer cells by promoting
epithelial-to-mesenchymal transition (EMT) and focal adhesion
formation. Cancer Cell Int. 17:542017. View Article : Google Scholar : PubMed/NCBI
|
